Art. 34. Certification of Certain Drugs. - (a) The Department shall, by regulations, provide for
the certification of batches of drugs composed wholly or partially of any kind of antibiotic. A batch of such drug shall be
certified if such drug has such characteristics of identity, strength, quality and purity, as the Department prescribes in
such regulations as necessary to insure adequately safety and efficacy of use and good quality, but shall not otherwise be
certified. Prior to the effective date of such regulations the Department, in lieu of certification, shall issue a release
for any batch which, in his judgment, may be released without risk as to the safety and efficacy of its use. Such release
shall prescribe the date of its expiration and other conditions under which it shall cease to be effective as to such batch
and as to portions thereof. For purposes of this Article and of Article 89 (j), the term "antibiotic drug" means any drug
intended for use by man containing any quantity of any chemical substance which is produced by a micro-organism and which
has the capacity to inhibit or destroy micro-organisms in dilute solution (including the chemically synthesized equivalent
of any such substance).
(b) Whenever in the judgment of the Department, the requirements of this Article and of Article 89
(j) with respect to any drug or class of drugs are not necessary to insure safety and efficacy of use and good quality, the
Department shall promulgate regulations exempting such drug or class of drugs from such requirements.
(c) The Department
shall promulgate regulations exempting from any requirement of this Article and of Article 89 (j), (l) drugs which are to
be stored, processed, labeled, or repacked at establishments other than those where manufactured, or condition that such drugs
comply with all such requirements upon removal from such establishments; (2) drugs which conform to applicable standards of
identity, strength, quality, and purity prescribed by these regulations and are intended for use in manufacturing other drugs;
and (3) drugs which are intended for investigational use by experts qualified by scientific training and experience to investigate
the safety and efficacy of drugs.